» Articles » PMID: 37870618

Socioeconomic Factors Associated with Poor Medication Adherence in Patients with Type 2 Diabetes

Overview
Specialty Pharmacology
Date 2023 Oct 23
PMID 37870618
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aims to determine initiation and persistence for patients with type 2 diabetes receiving their first prescription of an antidiabetic agent and the associations with socioeconomic factors.

Methods: A cohort study including 8515 patients with type 2 diabetes who were prescribed their first antidiabetic medication between 2012 and 2019 in Uppsala, Sweden, was followed during 2 years. Medical records were linked to national registers on dispensed drugs and socioeconomic data. Adherence was assessed based on patients' medication claims within 30 days of prescription (initiation) and continued claims after 24 months (persistence). Multivariable logistic regression was used to determine the associations with the socioeconomic factors age, sex, living status, country of birth, education, occupation, and income.

Results: Within 30 days, 92.4% of the patients claimed their first prescription, and 64.0% were still being dispensed the initially prescribed medication after 24 months. Unemployed patients had lower initiation rates, and women had lower persistence rates. Factors associated with both low initiation and persistence were low income, young or old age, birth outside Europe, and being prescribed other diabetes drugs than metformin monotherapy.

Conclusion: Socioeconomic factors have different impact on the initiation of a new medication and the persistence to treatment in type 2 diabetes. It is important to acknowledge these differences to develop appropriate interventions to improve medication nonadherence.

Citing Articles

Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services.

Kweyete O, Woods D, Okoumba J, Guo S, Allen J J Am Coll Clin Pharm. 2025; 8(1):47-51.

PMID: 40051646 PMC: 11880900. DOI: 10.1002/jac5.2050.


Relationship Between Depression and Decreased Activity Level and Cognitive Impairment in Patients with Diabetes Mellitus Type 2 and/or Atrial Fibrillation.

Militaru M, Lighezan D, Tudoran C, Zara F, Bucur A, Militaru A J Clin Med. 2025; 14(2).

PMID: 39860569 PMC: 11766045. DOI: 10.3390/jcm14020563.


Non-dispensed prescriptions - A nationwide descriptive study.

Kari H, Nurminen F, Ratto H, Koskinen H Explor Res Clin Soc Pharm. 2024; 16:100541.

PMID: 39650807 PMC: 11625144. DOI: 10.1016/j.rcsop.2024.100541.


Minding the gap: Assessing patient expectations versus experiences in drug information services at community health centers () in Indonesia urban settings.

Azizah R, Habibie H, Arsyad D, Bahar M Narra J. 2024; 4(2):e838.

PMID: 39280298 PMC: 11391965. DOI: 10.52225/narra.v4i2.838.


Asthma medication adherence, control, and psychological symptoms: a cross-sectional study.

Alqarni A, Aldhahir A, Siraj R, Alqahtani J, AlGhamdi D, Alghamdi S BMC Pulm Med. 2024; 24(1):189.

PMID: 38641584 PMC: 11031990. DOI: 10.1186/s12890-024-02995-x.

References
1.
Aikens J, Piette J . Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes. Diabet Med. 2012; 30(3):338-44. PMC: 3567301. DOI: 10.1111/dme.12046. View

2.
Ludvigsson J, Otterblad-Olausson P, Pettersson B, Ekbom A . The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009; 24(11):659-67. PMC: 2773709. DOI: 10.1007/s10654-009-9350-y. View

3.
Tang Y, Weiss T, Liu J, Rajpathak S, Khunti K . Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study. J Clin Transl Endocrinol. 2020; 20:100225. PMC: 7240214. DOI: 10.1016/j.jcte.2020.100225. View

4.
Evans M, Engberg S, Faurby M, Fernandes J, Hudson P, Polonsky W . Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes Obes Metab. 2021; 24(3):377-390. PMC: 9299643. DOI: 10.1111/dom.14603. View

5.
Davies M, Aroda V, Collins B, Gabbay R, Green J, Maruthur N . Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022; 45(11):2753-2786. PMC: 10008140. DOI: 10.2337/dci22-0034. View